Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis

被引：45

作者：

Zethraeus, N

Ben Sedrine, W

Caulin, F

Corcaud, S

Gathon, HJ

Haim, M

Johnell, O

Jönsson, B

Kanis, JA

Tsouderos, Y

Reginster, JY

机构：

[1] Stockholm Sch Econ, Ctr Hlth Econ, S-11383 Stockholm, Sweden

[2] WHO, Collaborating Ctr Publ Hlth Aspects Rheumat Disor, Liege, Belgium

[3] FC Consulting, Paris, France

[4] Grp Rech Servier, Neuilly Sur Seine, France

[5] Univ Liege, Dept Econ, Liege, Belgium

[6] Merck Sharp & Dohme SA, Paris, France

[7] Malmo Gen Hosp, Dept Orthopaed, SE-20202 Malmo, Sweden

[8] Univ Sheffield, WHO, Ctr Collaborat, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England

[9] Inst Rech Int Servier, F-92415 Courbevoie, France

来源：

OSTEOPOROSIS INTERNATIONAL | 2002年 / 13卷 / 11期

关键词：

D O I：

10.1007/s001980200117

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：841 / 857

页数：17

共 55 条

[1]

Akehurst R, 2000, PHARMACOECONOMICS, V17, P443

[2] Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus -: Results from the DIGAMI study [J].

Almbrand, B ;

Johannesson, M ;

Sjöstrand, B ;

Malmberg, K ;

Rydén, L .

EUROPEAN HEART JOURNAL, 2000, 21 (09) :733-739

[3] Handling uncertainty in cost-effectiveness models [J].

Briggs, AH .

PHARMACOECONOMICS, 2000, 17 (05) :479-500

[4] MENOPAUSAL ESTROGENS AND BREAST-CANCER RISK - AN EXPANDED CASE-CONTROL STUDY [J].

BRINTON, LA ;

HOOVER, R ;

FRAUMENI, JF .

BRITISH JOURNAL OF CANCER, 1986, 54 (05) :825-832

[5] EuroQol: The current state of play [J].

Brooks, R .

HEALTH POLICY, 1996, 37 (01) :53-72

[6] A COST-EFFECTIVENESS ANALYSIS OF HORMONE REPLACEMENT THERAPY IN THE MENOPAUSE [J].

CHEUNG, AP ;

WREN, BG .

MEDICAL JOURNAL OF AUSTRALIA, 1992, 156 (05) :312-316

[7] HRT - AN ANALYSIS OF BENEFITS, RISKS AND COSTS [J].

DALY, E ;

ROCHE, M ;

BARLOW, D ;

GRAY, A ;

MCPHERSON, K ;

VESSEY, M .

BRITISH MEDICAL BULLETIN, 1992, 48 (02) :368-400

[8] Hormone replacement therapy in a risk-benefit perspective [J].

Daly, E ;

Vessey, MP ;

Barlow, D ;

Gray, A ;

McPherson, K ;

Roche, M .

MATURITAS, 1996, 23 (02) :247-259

[9] MEASURING THE IMPACT OF MENOPAUSAL SYMPTOMS ON QUALITY-OF-LIFE [J].

DALY, E ;

GRAY, A ;

BARLOW, D ;

MCPHERSON, K ;

ROCHE, M ;

VESSEY, M .

BRITISH MEDICAL JOURNAL, 1993, 307 (6908) :836-840

[10] Modeling valuations for EuroQol health states [J].

Dolan, P .

MEDICAL CARE, 1997, 35 (11) :1095-1108

← 1 2 3 4 5 6 →